论文部分内容阅读
目的:分析研究重症新生儿呼吸窘迫综合征采取机械通气联合肺表面活性物质共同治疗的临床应用价值。方法:选取2013年2月-2014年2月在我院接收的患有重症呼吸窘迫综合征的患儿一共有78例,随机分为研究组、对照组,对照组对患儿单一采取机械通气治疗,研究组在此基础之上采取肺表面活性物质进行治疗,对研究组与对照组患儿各项观察指标改善情况以及治疗效果给予对比分析。结果:研究组临床治疗总体有效率明显要比对照组高(P<0.05);在治疗之前,两组患儿的PaO2以及PaCO2之间的差异不具有明显的统计学意义(P>0.05);治疗1h、24h以后,两组患儿的PaO2以及PaCO2的改善情况明显优于对照组(P<0.05)。结论:重症新生儿呼吸窘迫综合征采取机械通气联合肺表面活性物质共同治疗,可以使患儿相关症状得到明显改善,使治疗效果明显提高,具有临床推广价值。
Objective: To analyze the clinical value of mechanical ventilation combined with pulmonary surfactant in the treatment of severe neonatal respiratory distress syndrome. Methods: A total of 78 children admitted to our hospital from February 2013 to February 2014 in our hospital with severe respiratory distress syndrome were randomly divided into study group, control group and control group. The children received mechanical ventilation alone On the basis of this, the research group took pulmonary surfactant for treatment, and compared the improvement of various observation indexes and the treatment effect of the study group and the control group. Results: The overall effective rate of clinical treatment in study group was significantly higher than that in control group (P <0.05). Before treatment, PaO2 and PaCO2 in two groups had no significant difference (P> 0.05). The improvement of PaO2 and PaCO2 in both groups was significantly better than that of the control group (P <0.05) after treatment for 1h and 24h. Conclusion: Severe neonatal respiratory distress syndrome using mechanical ventilation combined with pulmonary surfactant co-treatment can be significantly improved in children with symptoms, the treatment effect was significantly improved, with clinical value.